Press release
Ad hoc announcement pursuant to Art. 53 LR
SHL Telemedicine’s Chairman announced he is stepping down
Following the August 2, 2024 announcement, Mr. Alroy informed the Company that he is also departing from the Company’s Board of Directors.
Tel Aviv / Zurich / New York, August 26, 2024 - SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has announced today that Mr. Yariv Alroy, Chairman of SHL, has informed the Company that he will be stepping down as Chairman and resign from the Board of Directors effective as of today.
The process of the board search committee to identify an appropriate person to be appointed as Chairman is progressing.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT, ISIN: US78423T2006, CUSIP: 78423T200).
For more information, please visit our website at www.shl-telemedicine.com.
Contacts
Fabienne Farner, IRF, Phone : +41 43 244 81 42, farner@irf-reputation.ch
Forward-Looking Statements
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.
